Skip to content

On this page

Eylea HD

aflibercept

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Eylea HD

Proper name

aflibercept

Licence type

351(a)

BLA number

761355

Applicant

Regeneron Pharmaceuticals, Inc.

Center

CDER

Presentations

1

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
8MG/0.07ML	Injection	Intravitreal	Single-Dose Vial	Rx	August 18, 2023

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity